Compile Data Set for Download or QSAR

Found 1 hit Enz. Inhib. hit(s) with Target = 'Muscarinic acetylcholine receptor M3' and Ligand = 'BDBM339881'   

Target/Host (Institution)	Ligand	Target/Host Links	Ligand Links	Trg + Lig Links	Ki nM	ΔG° kJ/mole	IC50 nM	Kd nM	EC50/IC50 nM	koff s-1	kon M-1s-1	pH	Temp °C
Muscarinic acetylcholine receptor M3 (Homo sapiens (Human))	BDBM339881 (US9757383, Example 4 | trans-4-[{3-[5-({[(2R)-2-hy...) Show SMILES CN(CCCn1ccc2cc(CNC[C@H](O)c3ccc(O)c4NCC=Cc34)ccc12)[C@H]1CC[C@@H](CC1)OC(=O)C(O)(c1cccs1)c1cccs1 |wU:30.33,14.14,wD:33.40,c:24,(4.07,14.5,;2.56,14.18,;2.09,12.71,;3.12,11.57,;4.62,11.89,;5.65,10.75,;7.19,10.91,;7.81,9.5,;6.67,8.47,;6.67,6.93,;5.33,6.16,;5.33,4.62,;4,3.85,;4,2.31,;2.67,1.54,;1.33,2.31,;2.67,,;1.33,-.77,;1.33,-2.31,;2.67,-3.08,;2.67,-4.62,;4,-2.31,;5.33,-3.08,;6.67,-2.31,;6.67,-.77,;5.33,,;4,-.77,;4,6.93,;4,8.47,;5.33,9.24,;1.53,15.32,;.03,15,;-1,16.15,;-.53,17.61,;.98,17.93,;2.01,16.79,;-1.56,18.76,;-3.06,18.44,;-3.54,16.97,;-4.1,19.58,;-5.24,18.55,;-5.13,20.73,;-4.81,22.23,;-6.14,23,;-7.28,21.97,;-6.66,20.57,;-2.95,20.61,;-1.44,20.29,;-.67,21.63,;-1.7,22.77,;-3.11,22.14,)| Show InChI InChI=1S/C40H46N4O5S2/c1-43(29-10-12-30(13-11-29)49-39(47)40(48,36-7-3-22-50-36)37-8-4-23-51-37)19-5-20-44-21-17-28-24-27(9-15-33(28)44)25-41-26-35(46)31-14-16-34(45)38-32(31)6-2-18-42-38/h2-4,6-9,14-17,21-24,29-30,35,41-42,45-46,48H,5,10-13,18-20,25-26H2,1H3/t29-,30-,35-/m0/s1	PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	0.600	n/a	n/a	n/a	n/a	n/a	n/a
Almirall, S.A. US Patent					Assay Description The study of binding to human muscarinic M1, M2, M3, M4 and M5 receptors was performed using commercial membranes (Perkin Elmer) prepared from CHO-K1...				US Patent US9757383 (2017) BindingDB Entry DOI: 10.7270/Q2HX1FSN
					More data for this Ligand-Target Pair